New water-soluble prodrugs of HIV protease inhibitors based on O→N intramolecular acyl migration

被引:51
作者
Hamada, Y [1 ]
Ohtake, J [1 ]
Sohma, Y [1 ]
Kimura, T [1 ]
Hayashi, Y [1 ]
Kiso, Y [1 ]
机构
[1] Kyoto Pharmaceut Univ, Dept Med Chem, Ctr Frontier Res Medicinal Sci, Yamashima Ku, Kyoto 6078412, Japan
关键词
D O I
10.1016/S0968-0896(02)00322-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To improve the low, water-solubility of HIV protease inhibitors. we synthesized water-soluble prodrugs of KN1-272 and KN1-279 which are potent HIV-1 protease inhibitors consisting of an Apns-Thz core structure (Apns: allophenylnorstatine, Thz: thiazolidine-4-carboxylic acid) as an inhibitory machinery. The prodrugs, which contained an O-acyl peptidomimetic structure with an ionized amino group leading to the increase of water-solubility were designed to regenerate the corresponding parent drugs based on the O-N intramolecular acyl migration reaction at the alpha-hydroxy-beta-amino acid residue, that is allophenylnorstatine. The synthetic prodrugs 3, 4, 6. and 7 improved the water-solubility (> 300 mg/ml) more than 4000-fold in comparison with the parent compounds. which is the practically acceptable value as water-soluble drugs. These prodrugs were stable as an HCl salt and in a strongly acidic solution corresponding to gastric juice (pH 2.0), and could be converted to the parent compounds promptly in the aqueous condition from slightly acidic to basic pH at 37 degreesC with the Suitable migration rate, via a five-membered ring intermediate. Using a similar method. we synthesized a prodrug (12) of ritonavir. a clinically useful HIV-1 protease inhibitor as an anti-AIDS drug. In contrast to the prodrugs 3, 4. 6. and 7, the prodrug 12 was very slowly converted to ritonavir probably through a six-membered ring intermediate, with the t(1/2) alue of 32 h that may not be suitable for practical use. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4155 / 4167
页数:13
相关论文
共 55 条
[1]  
ALRAZZAK LA, 1995, Patent No. 9507696
[2]   RENIN INHIBITORS CONTAINING HYDROPHILIC GROUPS - TETRAPEPTIDES WITH ENHANCED AQUEOUS SOLUBILITY AND NANOMOLAR POTENCY [J].
BOCK, MG ;
DIPARDO, RM ;
EVANS, BE ;
FREIDINGER, RM ;
RITTLE, KE ;
PAYNE, LS ;
BOGER, J ;
WHITTER, WL ;
LAMONT, BI ;
ULM, EH ;
BLAINE, EH ;
SCHORN, TW ;
VEBER, DF .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (10) :1918-1923
[3]  
BODANSZKY M, 1984, PRINCIPLES PEPTIDE S, P173
[4]   PEPTIDOMIMETIC HIV PROTEASE INHIBITORS - PHOSPHATE PRODRUGS WITH IMPROVED BIOLOGICAL-ACTIVITIES [J].
CHONG, KT ;
RUWART, MJ ;
HINSHAW, RR ;
WILKINSON, KF ;
RUSH, BD ;
YANCEY, MF ;
STROHBACH, JW ;
THAISRIVONGS, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (17) :2575-2577
[5]   THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS [J].
DEBOUCK, C .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :153-164
[6]   TOWARD IMPROVED ANTI-HIV CHEMOTHERAPY - THERAPEUTIC STRATEGIES FOR INTERVENTION WITH HIV-INFECTIONS [J].
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2491-2517
[7]   A COLON-SPECIFIC DRUG-DELIVERY SYSTEM BASED ON DRUG GLYCOSIDES AND THE GLYCOSIDASES OF COLONIC BACTERIA [J].
FRIEND, DR ;
CHANG, GW .
JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (03) :261-266
[8]  
HORIKI K, 1977, TETRAHEDRON LETT, P1897
[9]   HIV PROTEASE - A NOVEL CHEMOTHERAPEUTIC TARGET FOR AIDS [J].
HUFF, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (08) :2305-2314
[10]   ORALLY ACTIVE WATER-SOLUBLE N,O-ACYL TRANSFER PRODUCTS OF A BETA,GAMMA-BISHYDROXYL AMIDE CONTAINING RENIN INHIBITOR [J].
HURLEY, TR ;
COLSON, CE ;
HICKS, G ;
RYAN, MJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (10) :1496-1498